Gilead Sciences Inc. (GILD) Social Stream



Gilead Sciences Inc. (GILD): $74.83

0.18 (-0.24%)

POWR Rating

Component Grades

Momentum

F

Stability

B

Sentiment

Quality

B

Add GILD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#4 of 360

in industry

GILEAD SCIENCES INC (GILD) Price Targets From Analysts

Use the tables below to see what analysts covering GILEAD SCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-14 17 $100 $63 $78.5 $75.01 4.65%
2021-11-19 18 $100 $63 $79.428 $75.01 5.89%
2021-12-07 18 $100 $63 $79.266 $75.01 5.67%
2021-12-14 19 $100 $63 $78.812 $75.01 5.07%
2021-12-22 19 $100 $63 $79.125 $75.01 5.49%
2022-01-07 18 $100 $63 $79.25 $75.01 5.65%
2022-01-10 17 $100 $72 $80.714 $75.01 7.6%
2022-01-25 17 $100 $72 $80.571 $75.01 7.41%
2022-02-01 18 $100 $72 $80.571 $75.01 7.41%
2022-02-02 18 $100 $71 $79.714 $75.01 6.27%
2022-02-03 18 $100 $69 $78.928 $75.01 5.22%
2022-02-18 18 $90 $69 $78.214 $75.01 4.27%
2022-03-07 18 $90 $65 $77.5 $75.01 3.32%
2022-03-16 18 $90 $65 $77.142 $75.01 2.84%
2022-04-04 15 $90 $65 $76 $75.01 1.32%
2022-04-12 15 $90 $63 $75.083 $75.01 0.1%
2022-04-17 15 $90 $63 $74.75 $75.01 -0.35%
2022-04-29 15 $90 $63 $74.083 $75.01 -1.24%
2022-05-14 15 $90 $63 $74.166 $75.01 -1.13%
2022-05-16 15 $90 $63 $73.833 $75.01 -1.57%
2022-06-05 16 $90 $63 $72.769 $75.01 -2.99%
2022-08-03 17 $90 $65 $72.857 $75.01 -2.87%
2022-08-04 17 $90 $65 $72.923 $75.01 -2.78%
2022-08-14 17 $90 $65 $72.571 $75.01 -3.25%
2022-09-07 17 $90 $65 $72.785 $75.01 -2.97%
2022-09-17 17 $90 $65 $73.785 $75.01 -1.63%
2022-10-04 16 $90 $65 $74.357 $75.01 -0.87%
2022-10-21 17 $90 $60 $73.8 $75.01 -1.61%
2022-10-26 16 $90 $60 $74.2 $75.01 -1.08%
2022-10-28 16 $91 $60 $75.2 $75.01 0.25%
2022-10-31 18 $96 $60 $77.733 $75.01 3.63%
2022-11-07 18 $96 $68 $81.733 $75.01 8.96%
2022-11-08 19 $96 $27 $78.937 $75.01 5.24%
2022-11-28 19 $96 $27 $79.562 $75.01 6.07%
2022-12-01 18 $105 $27 $81 $75.01 7.99%
2022-12-12 19 $105 $27 $81 $75.01 7.99%
2022-12-21 19 $105 $27 $82.875 $75.01 10.49%
2023-01-03 19 $105 $27 $83.812 $75.01 11.73%
2023-01-09 19 $105 $27 $84.312 $75.01 12.4%
2023-01-22 19 $111 $27 $84.75 $75.01 12.98%
2023-01-23 19 $111 $27 $85.687 $75.01 14.23%
2023-01-27 19 $111 $27 $86.125 $75.01 14.82%
2023-02-03 18 $111 $27 $86.125 $75.01 14.82%
2023-02-06 18 $115 $27 $87.5 $75.01 16.65%
2023-02-08 18 $115 $27 $87.058 $75.01 16.06%
2023-02-13 18 $115 $27 $87.352 $75.01 16.45%
2023-02-24 18 $115 $72 $91.705 $75.01 22.26%
2023-04-06 17 $115 $72 $90.375 $75.01 20.48%
2023-04-21 17 $115 $72 $90.625 $75.01 20.82%
2023-04-28 17 $115 $72 $90.687 $75.01 20.9%
2023-05-01 18 $115 $72 $90.75 $75.01 20.98%
2023-05-15 18 $115 $72 $91.647 $75.01 22.18%
2023-05-16 18 $115 $72 $91.647 $75.01 22.18%
2023-07-11 18 $115 $80 $93.294 $75.01 24.38%
2023-07-17 18 $115 $80 $93.117 $75.01 24.14%
2023-07-24 18 $115 $80 $92.529 $75.01 23.36%
2023-07-25 18 $115 $80 $92.235 $75.01 22.96%
2023-08-04 18 $115 $80 $92.176 $75.01 22.88%
2023-08-07 18 $115 $80 $91.705 $75.01 22.26%
2023-09-06 18 $115 $71 $90.333 $75.01 20.43%
2023-09-07 18 $115 $71 $90.333 $75.01 20.43%
2023-09-11 18 $115 $71 $90.722 $75.01 20.95%

The Trend in the Analyst Price Target


Over the past 17 months, GILD's average price target has gone up $15.64.

Over the past 49 weeks, GILD's average upside potential has been 7.97%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-06 18 115 27 87.058 86.36 0.81%
2023-03-06 17 115 72 91.647 81.11 12.99%
2023-05-16 18 115 80 93.294 78.32 19.12%
2023-07-19 18 115 80 92.529 78.96 17.18%
2023-08-07 18 115 80 91.705 80.67 13.68%

GILD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.89 10 0 8 0 0 18

The Trend in the Broker Recommendations


GILD's average broker recommendation rating improved by 0.34 over the prior 44 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GILD as an investment opportunity.

  • In the context of all US stocks, GILEAD SCIENCES INC's number of analysts covering the stock is greater than 6313.74% of them.
  • In the context of Pharmaceutical Products stocks, GILEAD SCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 855.09% of them.
  • GILEAD SCIENCES INC's average analyst price target is greater than 5885.5% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GILEAD SCIENCES INC's variance in analysts' estimates is lower than -2252.38% of them.

Stocks similar to GILEAD SCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BIIB, AMGN, and TAK.

What is the outlook for GILD? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!